Sōhei Biotech

Sōhei Biotech is focused on developing psychedelic-based treatments for neuropsychiatric conditions. Their research centers around the potential of psychedelic compounds to address conditions such as PTSD, depression, and anxiety. Sōhei is exploring the therapeutic potential of psychedelic compounds when administered in a controlled setting with psychotherapy. Their research focuses on conditions such as PTSD, depression, and anxiety, which are often difficult to treat with traditional medications.

Jobs: